2026
Shaping death: how the microbiome regulates tumour cell demise and therapy response
RAUDENSKÁ, Martina; Jan BALVAN; Eliška ZGARBOVÁ; David KALFERT; Jan PLZAK et al.Základní údaje
Originální název
Shaping death: how the microbiome regulates tumour cell demise and therapy response
Autoři
RAUDENSKÁ, Martina ORCID; Jan BALVAN; Eliška ZGARBOVÁ ORCID; David KALFERT; Jan PLZAK a Michal MASAŘÍK
Vydání
CANCER AND METASTASIS REVIEWS, DORDRECHT, SPRINGER, 2026, 0167-7659
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 8.700 v roce 2024
Označené pro přenos do RIV
Ano
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Cell death; Apoptosis; Ferroptosis; Microbial metabolites; Cancer metabolism; Cancer therapy; Microbiome
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 4. 2026 12:44, Mgr. Tereza Miškechová
Anotace
V originále
Cell death is a fundamental process that maintains tissue homeostasis and shapes the tumour microenvironment. Cancer cells often evade or reprogram cell death pathways, which leads to malignancy and therapy resistance. On the other hand, the cell death of non-malignant cells significantly influences the adverse effects of anticancer therapy, such as the onset of mucositis or enteritis. Emerging evidence identifies both the tumour and gut microbiomes as critical modulators of these processes. In turn, cell death reshapes the microbial ecosystem by altering nutrient landscapes and immune signalling. Although both cell death and the microbiome are well-studied in cancer, their intersection remains underexplored. This review article addresses this gap by summarising how microbes and microbial metabolites modulate cancer cell death pathways and shape responses to anticancer therapy. We integrated current knowledge on this complex interplay, focusing on key metabolic mediators that can influence cell fate decisions. Understanding this bidirectional crosstalk offers new opportunities to "preserve the good and eliminate the bad" within the tumour-microbiome axis, paving the way for precision microbiome-informed cancer therapies.
Návaznosti
| MUNI/A/1790/2024, interní kód MU |
| ||
| NU23-03-00274, projekt VaV |
|